Reference List

These 333 refereces (329 papers / 2 book sections / 2 appliations) are refered from the Map Paper :

"A comprehensive map of the influenza A virus replication cycle"

 

Papers

• Akarsu H, Burmeister WP, Petosa C, Petit I, Muller CW, Ruigrok RW, Baudin F: Crystal structure of the M1 protein-binding domain of the influenza A virus nuclear export protein (NEP/NS2). EMBO J 2003, 22(18):4646-4655.
• Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity 2009, 30(4):556-565.
• Almond JW, Felsenreich V: Phosphorylation of the nucleoprotein of an avian influenza virus. J Gen Virol 1982, 60(Pt 2):295-305.
  
• Alonso-Caplen FV, Nemeroff ME, Qiu Y, Krug RM: Nucleocytoplasmic transport: the influenza virus NS1 protein regulates the transport of spliced NS2 mRNA and its precursor NS1 mRNA. Genes Dev 1992, 6(2):255-267.
  
• Amorim MJ, Bruce EA, Read EK, Foeglein A, Mahen R, Stuart AD, Digard P: A Rab11- and microtubule-dependent mechanism for cytoplasmic transport of influenza A virus viral RNA. Journal of virology 2011, 85(9):4143-4156.
  
• Amorim MJ, Kao RY, Digard P: Nucleozin targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection. Journal of virology 2013, 87(8):4694-4703.
  
• Arrese M, Portela A: Serine 3 is critical for phosphorylation at the N-terminal end of the nucleoprotein of influenza virus A/Victoria/3/75. Journal of virology 1996, 70(6):3385-3391.
  
• Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D: The influenza virus resource at the National Center for Biotechnology Information. Journal of virology 2008, 82(2):596-601.
  
• Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel JJ, Knossow M: An antibody that prevents the hemagglutinin low pH fusogenic transition. Virology 2002, 294(1):70-74.
  
• Barman S, Adhikary L, Chakrabarti AK, Bernas C, Kawaoka Y, Nayak DP: Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding. Journal of virology 2004, 78(10):5258-5269.
  
• Barman S, Ali A, Hui EK, Adhikary L, Nayak DP: Transport of viral proteins to the apical membranes and interaction of matrix protein with glycoproteins in the assembly of influenza viruses. Virus Res 2001, 77(1):61-69.
  
• Barman S, Nayak DP: Analysis of the transmembrane domain of influenza virus neuraminidase, a type II transmembrane glycoprotein, for apical sorting and raft association. Journal of virology 2000, 74(14):6538-6545.
  
• Basu D, Walkiewicz MP, Frieman M, Baric RS, Auble DT, Engel DA: Novel influenza virus NS1 antagonists block replication and restore innate immune function. Journal of virology 2009, 83(4):1881-1891.
  
• Baudin F, Petit I, Weissenhorn W, Ruigrok RW: In vitro dissection of the membrane and RNP binding activities of influenza virus M1 protein. Virology 2001, 281(1):102-108.
  
• Baum LG, Paulson JC: Sialyloligosaccharides of the respiratory epithelium in the selection of human influenza virus receptor specificity. Acta Histochem Suppl 1990, 40:35-38.
  
• Bergmann M, Garcia-Sastre A, Carnero E, Pehamberger H, Wolff K, Palese P, Muster T: Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. Journal of virology 2000, 74(13):6203-6206.
  
• Bier K, York A, Fodor E: Cellular cap-binding proteins associate with influenza virus mRNAs. J Gen Virol 2011, 92(Pt 7):1627-1634.
  
• Birnkrant D, Cox E: The Emergency Use Authorization of peramivir for treatment of 2009 H1N1 influenza. N Engl J Med 2009, 361(23):2204-2207.
  
• Blaas D, Patzelt E, Kuechler E: Cap-recognizing protein of influenza virus. Virology 1982, 116(1):339-348.
  
• Blaas D, Patzelt E, Kuechler E: Identification of the cap binding protein of influenza virus. Nucleic acids research 1982, 10(15):4803-4812.
  
• Boivin S, Cusack S, Ruigrok RW, Hart DJ: Influenza A virus polymerase: structural insights into replication and host adaptation mechanisms. J Biol Chem 2010, 285(37):28411-28417.
  
• Bottcher-Friebertshauser E, Freuer C, Sielaff F, Schmidt S, Eickmann M, Uhlendorff J, Steinmetzer T, Klenk HD, Garten W: Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. Journal of virology 2010, 84(11):5605-5614.
  
• Braam J, Ulmanen I, Krug RM: Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription. Cell 1983, 34(2):609-618.
  
• Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, Ryan BJ, Weyer JL, van der Weyden L, Fikrig E et al: The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 2009, 139(7):1243-1254.
  
• Brooks MJ, Burtseva EI, Ellery PJ, Marsh GA, Lew AM, Slepushkin AN, Crowe SM, Tannock GA: Antiviral activity of arbidol, a broad-spectrum drug for use against respiratory viruses, varies according to test conditions. Journal of medical virology 2012, 84(1):170-181.
  
• Bruce EA, Digard P, Stuart AD: The Rab11 pathway is required for influenza A virus budding and filament formation. Journal of virology 2010, 84(12):5848-5859.
  
• Bui M, Myers JE, Whittaker GR: Nucleo-cytoplasmic localization of influenza virus nucleoprotein depends on cell density and phosphorylation. Virus Res 2002, 84(1-2):37-44.
  
• Bui M, Whittaker G, Helenius A: Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. Journal of virology 1996, 70(12):8391-8401.
  
• Bui M, Wills EG, Helenius A, Whittaker GR: Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. Journal of virology 2000, 74(4):1781-1786.
  
• Bullido R, Gómez-Puertas P, Albo C, Portela A: Several protein regions contribute to determine the nuclear and cytoplasmic localization of the influenza A virus nucleoprotein. J Gen Virol 2000, 81(Pt 1):135-142.
  
• Burgui I, Aragon T, Ortin J, Nieto A: PABP1 and eIF4GI associate with influenza virus NS1 protein in viral mRNA translation initiation complexes. J Gen Virol 2003, 84(Pt 12):3263-3274.
  
• Calzone L, Gelay A, Zinovyev A, Radvanyi F, Barillot E: A comprehensive modular map of molecular interactions in RB/E2F pathway. Molecular systems biology 2008, 4:173-173.
  
• Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PK et al: Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. Journal of virology 2008, 82(22):11308-11317.
  
• Cao S, Liu X, Yu M, Li J, Jia X, Bi Y, Sun L, Gao GF, Liu W: A nuclear export signal in the matrix protein of Influenza A virus is required for efficient virus replication. Journal of virology 2012, 86(9):4883-4891.
  
• Caron E, Ghosh S, Matsuoka Y, Ashton-Beaucage D, Therrien M, Lemieux S, Perreault C, Roux PP, Kitano H: A comprehensive map of the mTOR signaling network. Molecular systems biology 2010, 6:453-453.
  
• Chan RW, Chan MC, Wong AC, Karamanska R, Dell A, Haslam SM, Sihoe AD, Chui WH, Triana-Baltzer G, Li Q et al: DAS181 inhibits H5N1 influenza virus infection of human lung tissues. Antimicrob Agents Chemother 2009, 53(9):3935-3941.
  
• Chan-Tack KM, Murray JS, Birnkrant DB: Use of ribavirin to treat influenza. N Engl J Med 2009, 361(17):1713-1714.
  
• Chanturiya AN, Basanez G, Schubert U, Henklein P, Yewdell JW, Zimmerberg J: PB1-F2, an influenza A virus-encoded proapoptotic mitochondrial protein, creates variably sized pores in planar lipid membranes. Journal of virology 2004, 78(12):6304-6312.
  
• Chase GP, Rameix-Welti MA, Zvirbliene A, Zvirblis G, Gotz V, Wolff T, Naffakh N, Schwemmle M: Influenza virus ribonucleoprotein complexes gain preferential access to cellular export machinery through chromatin targeting. PLoS Pathog 2011, 7(9):e1002187.
  
• Chatr-aryamontri A, Ceol A, Peluso D, Nardozza A, Panni S, Sacco F, Tinti M, Smolyar A, Castagnoli L, Vidal M et al: VirusMINT: a viral protein interaction database. Nucleic acids research 2009, 37(Database issue):D669-D673.
  
• Chen W, Calvo PA, Malide D, Gibbs J, Schubert U, Bacik I, Basta S, O'Neill R, Schickli J, Palese P et al: A novel influenza A virus mitochondrial protein that induces cell death. Nat Med 2001, 7(12):1306-1312.
  
• Chen Z, Krug RM: Selective nuclear export of viral mRNAs in influenza-virus-infected cells. Trends in microbiology 2000, 8(8):376-383.
  
• Chen Z, Li Y, Krug RM: Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J 1999, 18(8):2273-2283.
  
• Cilloniz C, Pantin-Jackwood MJ, Ni C, Goodman AG, Peng X, Proll SC, Carter VS, Rosenzweig ER, Szretter KJ, Katz JM et al: Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection. Journal of virology 2010, 84(15):7613-7624.
  
• Cilloniz C, Shinya K, Peng X, Korth MJ, Proll SC, Aicher LD, Carter VS, Chang JH, Kobasa D, Feldmann F et al: Lethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genes. PLoS Pathog 2009, 5(10):e1000604.
  
• Conenello GM, Zamarin D, Perrone LA, Tumpey T, Palese P: A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence. PLoS Pathog 2007, 3(10):1414-1421.
  
• Connor RJ, Kawaoka Y, Webster RG, Paulson JC: Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 1994, 205(1):17-23.
  
• Coombs KM, Berard A, Xu W, Krokhin O, Meng X, Cortens JP, Kobasa D, Wilkins J, Brown EG: Quantitative proteomic analyses of influenza virus-infected cultured human lung cells. Journal of virology 2010, 84(20):10888-10906.
  
• Couceiro JN, Paulson JC, Baum LG: Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium; the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res 1993, 29(2):155-165.
  
• Cros JF, Garcia-Sastre A, Palese P: An unconventional NLS is critical for the nuclear import of the influenza A virus nucleoprotein and ribonucleoprotein. Traffic 2005, 6(3):205-213.
  
• Cros JF, Palese P: Trafficking of viral genomic RNA into and out of the nucleus: influenza, Thogoto and Borna disease viruses. Virus Res 2003, 95(1-2):3-12.
  
• De Clercq E: Antiviral agents active against influenza A viruses. Nature reviews Drug discovery 2006, 5(12):1015-1025.
  
• de Vries E, Tscherne DM, Wienholts MJ, Cobos-Jimenez V, Scholte F, Garcia-Sastre A, Rottier PJ, de Haan CA: Dissection of the influenza A virus endocytic routes reveals macropinocytosis as an alternative entry pathway. PLoS Pathog 2011, 7(3):e1001329.
  
• Deng T, Engelhardt OG, Thomas B, Akoulitchev AV, Brownlee GG, Fodor E: Role of ran binding protein 5 in nuclear import and assembly of the influenza virus RNA polymerase complex. Journal of virology 2006, 80(24):11911-11919.
  
• Deng T, Sharps J, Fodor E, Brownlee GG: In vitro assembly of PB2 with a PB1-PA dimer supports a new model of assembly of influenza A virus polymerase subunits into a functional trimeric complex. Journal of virology 2005, 79(13):8669-8674.
  
• Dias A, Bouvier D, Crepin T, McCarthy AA, Hart DJ, Baudin F, Cusack S, Ruigrok RW: The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 2009, 458(7240):914-918.
  
• Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C: Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303(5663):1529-1531.
  
• Dittmann J, Stertz S, Grimm D, Steel J, Garcia-Sastre A, Haller O, Kochs G: Influenza A virus strains differ in sensitivity to the antiviral action of Mx-GTPase. Journal of virology 2008, 82(7):3624-3631.
  
• Droebner K, Pleschka S, Ludwig S, Planz O: Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antiviral research 2011, 92(2):195-203.
  
• Ehrhardt C, Marjuki H, Wolff T, Nurnberg B, Planz O, Pleschka S, Ludwig S: Bivalent role of the phosphatidylinositol-3-kinase (PI3K) during influenza virus infection and host cell defence. Cell Microbiol 2006, 8(8):1336-1348.
  
• Ehrhardt C, Seyer R, Hrincius ER, Eierhoff T, Wolff T, Ludwig S: Interplay between influenza A virus and the innate immune signaling. Microbes and infection / Institut Pasteur 2010, 12(1):81-87.
  
• Ehrhardt C, Wolff T, Ludwig S: Activation of phosphatidylinositol 3-kinase signaling by the nonstructural NS1 protein is not conserved among type A and B influenza viruses. Journal of virology 2007, 81(21):12097-12100.
  
• Ehrhardt C, Wolff T, Pleschka S, Planz O, Beermann W, Bode JG, Schmolke M, Ludwig S: Influenza A virus NS1 protein activates the PI3K/Akt pathway to mediate antiapoptotic signaling responses. Journal of virology 2007, 81(7):3058-3067.
  
• Eisfeld AJ, Kawakami E, Watanabe T, Neumann G, Kawaoka Y: RAB11A is essential for transport of the influenza virus genome to the plasma membrane. Journal of virology 2011, 85(13):6117-6126.
  
• Eisfeld AJ, Neumann G, Kawaoka Y: Human immunodeficiency virus rev-binding protein is essential for influenza a virus replication and promotes genome trafficking in late-stage infection. Journal of virology 2011, 85(18):9588-9598.
  
• Ekiert DC, Bhabha G, Elsliger MA, Friesen RH, Jongeneelen M, Throsby M, Goudsmit J, Wilson IA: Antibody recognition of a highly conserved influenza virus epitope. Science 2009, 324(5924):246-251.
  
• Enami M, Enami K: Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. Journal of virology 1996, 70(10):6653-6657.
  
• Engelhardt OG, Fodor E: Functional association between viral and cellular transcription during influenza virus infection. Rev Med Virol 2006, 16(5):329-345.
  
• Engelhardt OG, Smith M, Fodor E: Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. Journal of virology 2005, 79(9):5812-5818.
  
• Eyers S, Weatherall M, Shirtcliffe P, Perrin K, Beasley R: The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. Journal of the Royal Society of Medicine 2010, 103(10):403-411.
  
• Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, Gaiha GD, Ryan BJ, Donis RO, Elledge SJ et al: IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog 2011, 7(10):e1002337.
  
• Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM: Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2011, 60(1):1-24.
  
• Fodor E, Smith M: The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. Journal of virology 2004, 78(17):9144-9153.
  
• Fortes P, Beloso A, Ortin J: Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport. EMBO J 1994, 13(3):704-712.
  
• Fujii Y, Goto H, Watanabe T, Yoshida T, Kawaoka Y: Selective incorporation of influenza virus RNA segments into virions. Proc Natl Acad Sci U S A 2003, 100(4):2002-2007.
  
• Funahashi A, Matsuoka Y, Jouraku A, Morohashi M, Kikuchi N, Kitano H: CellDesigner 3.5: A Versatile Modeling Tool for Biochemical Networks. Proceedings of the IEEE 2008, 96(8):1254-1265.
  
• Furuta Y, Takahashi K, Kuno-Maekawa M, Sangawa H, Uehara S, Kozaki K, Nomura N, Egawa H, Shiraki K: Mechanism of action of T-705 against influenza virus. Antimicrob Agents Chemother 2005, 49(3):981-986.
  
• Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A: Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 2009, 5(5):439-449.
  
• Gambaryan AS, Tuzikov AB, Piskarev VE, Yamnikova SS, Lvov DK, Robertson JS, Bovin NV, Matrosovich MN: Specification of receptor-binding phenotypes of influenza virus isolates from different hosts using synthetic sialylglycopolymers: non-egg-adapted human H1 and H3 influenza A and influenza B viruses share a common high binding affinity for 6'-sialyl(N-acetyllactosamine). Virology 1997, 232(2):345-350.
  
• Garcia-Sastre A: Induction and evasion of type I interferon responses by influenza viruses. Virus research 2011, 162(1-2):12-18.
  
• García-Sastre A: Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 2001, 279(2):375-384.
  
• Geiler J, Michaelis M, Sithisarn P, Cinatl J, Jr.: Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol 2011, 200(1):53-60.
  
• Gerritz SW, Cianci C, Kim S, Pearce BC, Deminie C, Discotto L, McAuliffe B, Minassian BF, Shi S, Zhu S et al: Inhibition of influenza virus replication via small molecules that induce the formation of higher-order nucleoprotein oligomers. Proc Natl Acad Sci U S A 2011, 108(37):15366-15371.
  
• Gibbs JS, Malide D, Hornung F, Bennink JR, Yewdell JW: The influenza A virus PB1-F2 protein targets the inner mitochondrial membrane via a predicted basic amphipathic helix that disrupts mitochondrial function. Journal of virology 2003, 77(13):7214-7224.
  
• Golebiewski L, Liu H, Javier RT, Rice AP: The Avian Influenza NS1 ESEV PDZ Binding Motif Associates with Dlg1 and Scribble to Disrupt Cellular Tight Junctions. Journal of virology 2011.
  
• Gorai T, Goto H, Noda T, Watanabe T, Kozuka-Hata H, Oyama M, Takano R, Neumann G, Watanabe S, Kawaoka Y: F1Fo-ATPase, F-type proton-translocating ATPase, at the plasma membrane is critical for efficient influenza virus budding. Proc Natl Acad Sci U S A 2012, 109(12):4615-4620.
  
• Greenspan D, Krystal M, Nakada S, Arnheiter H, Lyles DS, Palese P: Expression of influenza virus NS2 nonstructural protein in bacteria and localization of NS2 in infected eucaryotic cells. Journal of virology 1985, 54(3):833-843.
  
• Greenspan D, Palese P, Krystal M: Two nuclear location signals in the influenza virus NS1 nonstructural protein. Journal of virology 1988, 62(8):3020-3026.
  
• Gregoriades A, Guzman GG, Paoletti E: The phosphorylation of the integral membrane (M1) protein of influenza virus. Virus Res 1990, 16(1):27-41.
  
• Guan ZH, Zhang ML, Hou PL, Duan M, Cui YM, Wang XR: Identification of cellular proteins interacting with influenza A virus PB1-F2 protein. Acta virologica 2012, 56(3):199-207.
  
• Guillot L, Le Goffic R, Bloch S, Escriou N, Akira S, Chignard M, Si-Tahar M: Involvement of toll-like receptor 3 in the immune response of lung epithelial cells to double-stranded RNA and influenza A virus. J Biol Chem 2005, 280(7):5571-5580.
  
• Hale BG, Batty IH, Downes CP, Randall RE: Binding of influenza A virus NS1 protein to the inter-SH2 domain of p85 suggests a novel mechanism for phosphoinositide 3-kinase activation. J Biol Chem 2008, 283(3):1372-1380.
  
• Hale BG, Jackson D, Chen YH, Lamb RA, Randall RE: Influenza A virus NS1 protein binds p85beta and activates phosphatidylinositol-3-kinase signaling. Proc Natl Acad Sci U S A 2006, 103(38):14194-14199.
  
• Hale BG, Kerry PS, Jackson D, Precious BL, Gray A, Killip MJ, Randall RE, Russell RJ: Structural insights into phosphoinositide 3-kinase activation by the influenza A virus NS1 protein. Proc Natl Acad Sci U S A 2010, 107(5):1954-1959.
  
• Hale BG, Knebel A, Botting CH, Galloway CS, Precious BL, Jackson D, Elliott RM, Randall RE: CDK/ERK-mediated phosphorylation of the human influenza A virus NS1 protein at threonine-215. Virology 2009, 383(1):6-11.
  
• Hale BG, Randall RE, Ortin J, Jackson D: The multifunctional NS1 protein of influenza A viruses. J Gen Virol 2008, 89(Pt 10):2359-2376.
  
• Hale BG, Randall RE: PI3K signalling during influenza A virus infections. Biochem Soc Trans 2007, 35(Pt 2):186-187.
  
• Haller O, Arnheiter H, Lindenmann J, Gresser I: Host gene influences sensitivity to interferon action selectively for influenza virus. Nature 1980, 283(5748):660-662.
  
• Haller O, Kochs G: Interferon-induced mx proteins: dynamin-like GTPases with antiviral activity. Traffic 2002, 3(10):710-717.
  
• Haller O, Staeheli P, Kochs G: Protective role of interferon-induced Mx GTPases against influenza viruses. Rev Sci Tech 2009, 28(1):219-231.
  
• Hao L, Sakurai A, Watanabe T, Sorensen E, Nidom CA, Newton MA, Ahlquist P, Kawaoka Y: Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 2008, 454(7206):890-893.
  
• Hatada E, Saito S, Fukuda R: Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells. Journal of virology 1999, 73(3):2425-2433.
  
• Helenius A: Unpacking the incoming influenza virus. Cell 1992, 69(4):577-578.
  
• Henkel M, Mitzner D, Henklein P, Meyer-Almes FJ, Moroni A, Difrancesco ML, Henkes LM, Kreim M, Kast SM, Schubert U et al: The proapoptotic influenza A virus protein PB1-F2 forms a nonselective ion channel. PLoS One 2010, 5(6):e11112.
  
• Hernandez JE, Adiga R, Armstrong R, Bazan J, Bonilla H, Bradley J, Dretler R, Ison MG, Mangino JE, Maroushek S et al: Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States. Clin Infect Dis 2011, 52(6):695-706.
  
• Heynisch B, Frensing T, Heinze K, Seitz C, Genzel Y, Reichl U: Differential activation of host cell signalling pathways through infection with two variants of influenza A/Puerto Rico/8/34 (H1N1) in MDCK cells. Vaccine 2010, 28(51):8210-8218.
  
• Hoffmann R, Valencia A: A gene network for navigating the literature. Nature Genetics 2004, 36(7):664-664.
  
• Horimoto T, Kawaoka Y: Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. Journal of virology 1994, 68(5):3120-3128.
  
• Hrincius ER, Dierkes R, Anhlan D, Wixler V, Ludwig S, Ehrhardt C: Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production. Cell Microbiol 2011, 13(12):1907-1919.
  
• Hsiang TY, Zhou L, Krug RM: Roles of the phosphorylation of specific serines and threonines in the NS1 protein of human influenza A viruses. Journal of virology 2012, 86(19):10370-10376.
  
• Huang X, Liu T, Muller J, Levandowski RA, Ye Z: Effect of influenza virus matrix protein and viral RNA on ribonucleoprotein formation and nuclear export. Virology 2001, 287(2):405-416.
  
• Hucka M, Finney A, Sauro HM, Bolouri H, Doyle JC, Kitano H, Arkin AP, Bornstein BJ, Bray D, Cornish-Bowden A et al: The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003, 19(4):524-531.
  
• Hutchinson EC, Fodor E: Nuclear import of the influenza A virus transcriptional machinery. Vaccine 2012, 30(51):7353-7358.
  
• Hutchinson EC, Orr OE, Man Liu S, Engelhardt OG, Fodor E: Characterization of the interaction between the influenza A virus polymerase subunit PB1 and the host nuclear import factor Ran-binding protein 5. J Gen Virol 2011, 92(Pt 8):1859-1869.
  
• Hutchinson EC, von Kirchbach JC, Gog JR, Digard P: Genome packaging in influenza A virus. J Gen Virol 2010, 91(Pt 2):313-328.
  
• Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A: Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med 2009, 206(1):79-87.
  
• Ichinohe T, Pang IK, Iwasaki A: Influenza virus activates inflammasomes via its intracellular M2 ion channel. Nature immunology 2010, 11(5):404-410.
  
• Ito T, Kawaoka Y: Host-range barrier of influenza A viruses. Vet Microbiol 2000, 74(1-2):71-75.
  
• Ito T, Suzuki Y, Suzuki T, Takada A, Horimoto T, Wells K, Kida H, Otsuki K, Kiso M, Ishida H et al: Recognition of N-glycolylneuraminic acid linked to galactose by the alpha2,3 linkage is associated with intestinal replication of influenza A virus in ducks. Journal of virology 2000, 74(19):9300-9305.
  
• Iverson AR, Boyd KL, McAuley JL, Plano LR, Hart ME, McCullers JA: Influenza virus primes mice for pneumonia from Staphylococcus aureus. J Infect Dis 2011, 203(6):880-888.
  
• Iwatsuki-Horimoto K, Horimoto T, Fujii Y, Kawaoka Y: Generation of influenza A virus NS2 (NEP) mutants with an altered nuclear export signal sequence. Journal of virology 2004, 78(18):10149-10155.
  
• Jablonski JJ, Basu D, Engel DA, Geysen HM: Design, synthesis, and evaluation of novel small molecule inhibitors of the influenza virus protein NS1. Bioorganic & medicinal chemistry 2012, 20(1):487-497.
  
• Jackson D, Hossain MJ, Hickman D, Perez DR, Lamb RA: A new influenza virus virulence determinant: the NS1 protein four C-terminal residues modulate pathogenicity. Proc Natl Acad Sci U S A 2008, 105(11):4381-4386.
  
• Javier RT, Rice AP: Emerging theme: cellular PDZ proteins as common targets of pathogenic viruses. Journal of virology 2011, 85(22):11544-11556.
  
• Jones IM, Reay PA, Philpott KL: Nuclear location of all three influenza polymerase proteins and a nuclear signal in polymerase PB2. The EMBO journal 1986, 5(9):2371-2376.
  
• Jorba N, Juarez S, Torreira E, Gastaminza P, Zamarreno N, Albar JP, Ortin J: Analysis of the interaction of influenza virus polymerase complex with human cell factors. Proteomics 2008, 8(10):2077-2088.
  
• Joshi-Tope G, Gillespie M, Vastrik I, D'Eustachio P, Schmidt E, de Bono B, Jassal B, Gopinath GR, Wu GR, Matthews L et al: Reactome: a knowledgebase of biological pathways. Nucleic acids research 2005, 33(Database issue):D428-D432.
  
• Kaizu K, Ghosh S, Matsuoka Y, Moriya H, Shimizu-Yoshida Y, Kitano H: A comprehensive molecular interaction map of the budding yeast cell cycle. Molecular systems biology 2010, 6:415-415.
  
• Kanehisa M, Goto S: KEGG: kyoto encyclopedia of genes and genomes. Nucleic acids research 2000, 28(1):27-30.
  
• Kao RY, Yang D, Lau LS, Tsui WH, Hu L, Dai J, Chan MP, Chan CM, Wang P, Zheng BJ et al: Identification of influenza A nucleoprotein as an antiviral target. Nat Biotechnol 2010, 28(6):600-605.
  
• Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S et al: Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 2010, 463(7282):818-822.
  
• Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ et al: Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441(7089):101-105.
  
• Katze MG, Chen YT, Krug RM: Nuclear-cytoplasmic transport and VAI RNA-independent translation of influenza viral messenger RNAs in late adenovirus-infected cells. Cell 1984, 37(2):483-490.
  
• Katze MG, DeCorato D, Krug RM: Cellular mRNA translation is blocked at both initiation and elongation after infection by influenza virus or adenovirus. Journal of virology 1986, 60(3):1027-1039.
  
• Katze MG, Detjen BM, Safer B, Krug RM: Translational control by influenza virus: suppression of the kinase that phosphorylates the alpha subunit of initiation factor eIF-2 and selective translation of influenza viral mRNAs. Molecular and cellular biology 1986, 6(5):1741-1750.
  
• Kawaguchi A, Matsumoto K, Nagata K: YB-1 functions as a porter to lead influenza virus ribonucleoprotein complexes to microtubules. Journal of virology 2012, 86(20):11086-11095.
  
• Kim CU, Lew W, Williams MA, Liu H, Zhang L, Swaminathan S, Bischofberger N, Chen MS, Mendel DB, Tai CY et al: Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J Am Chem Soc 1997, 119(4):681-690.
  
• Kiso M, Kubo S, Ozawa M, Le QM, Nidom CA, Yamashita M, Kawaoka Y: Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses. PLoS Pathog 2010, 6(2):e1000786.
  
• Kiso M, Takahashi K, Sakai-Tagawa Y, Shinya K, Sakabe S, Le QM, Ozawa M, Furuta Y, Kawaoka Y: T-705 (favipiravir) activity against lethal H5N1 influenza A viruses. Proc Natl Acad Sci U S A 2010, 107(2):882-887.
  
• Kistner O, Muller K, Scholtissek C: Differential phosphorylation of the nucleoprotein of influenza A viruses. J Gen Virol 1989, 70 ( Pt 9):2421-2431.
  
• Kitano H, Funahashi A, Matsuoka Y, Oda K: Using process diagrams for the graphical representation of biological networks. Nature biotechnology 2005, 23(8):961-966.
  
• Klenk HD, Wagner R, Heuer D, Wolff T: Importance of hemagglutinin glycosylation for the biological functions of influenza virus. Virus Res 2002, 82(1-2):73-75.
  
• Knossow M, Gaudier M, Douglas A, Barrère B, Bizebard T, Barbey C, Gigant B, Skehel JJ: Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 2002, 302(2):294-298.
  
• Konig R, Stertz S, Zhou Y, Inoue A, Hoffmann HH, Bhattacharyya S, Alamares JG, Tscherne DM, Ortigoza MB, Liang Y et al: Human host factors required for influenza virus replication. Nature 2010, 463(7282):813-817.
  
• Kotlyar M, Fortney K, Jurisica I: Network-based characterization of drug-regulated genes, drug targets, and toxicity. Methods (San Diego, Calif) 2012, 57(4):499-507.
  
• Kujime K, Hashimoto S, Gon Y, Shimizu K, Horie T: p38 mitogen-activated protein kinase and c-jun-NH2-terminal kinase regulate RANTES production by influenza virus-infected human bronchial epithelial cells. J Immunol 2000, 164(6):3222-3228.
  
• Kundu A, Avalos RT, Sanderson CM, Nayak DP: Transmembrane domain of influenza virus neuraminidase, a type II protein, possesses an apical sorting signal in polarized MDCK cells. Journal of virology 1996, 70(9):6508-6515.
  
• Le Goffic R, Balloy V, Lagranderie M, Alexopoulou L, Escriou N, Flavell R, Chignard M, Si-Tahar M: Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus-induced acute pneumonia. PLoS Pathog 2006, 2(6):e53.
  
• Le Goffic R, Pothlichet J, Vitour D, Fujita T, Meurs E, Chignard M, Si-Tahar M: Cutting Edge: Influenza A virus activates TLR3-dependent inflammatory and RIG-I-dependent antiviral responses in human lung epithelial cells. J Immunol 2007, 178(6):3368-3372.
  
• Le Novère N, Finney A, Hucka M, Bhalla US, Campagne F, Collado-Vides J, Crampin EJ, Halstead M, Klipp E, Mendes P et al: Minimum information requested in the annotation of biochemical models (MIRIAM). Nature biotechnology 2005, 23(12):1509-1515.
  
• Le Novère N, Hucka M, Mi H, Moodie S, Schreiber F, Sorokin A, Demir E, Wegner K, Aladjem MI, Wimalaratne SM et al: The Systems Biology Graphical Notation. Nature biotechnology 2009, 27(8):735-741.
  
• Leser GP, Lamb RA: Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins. Virology 2005, 342(2):215-227.
  
• Li C, Bankhead A, 3rd, Eisfeld AJ, Hatta Y, Jeng S, Chang JH, Aicher LD, Proll S, Ellis AL, Law GL et al: Host regulatory network response to infection with highly pathogenic H5N1 avian influenza virus. Journal of virology 2011, 85(21):10955-10967.
  
• Li F, Thiele I, Jamshidi N, Palsson BØ: Identification of potential pathway mediation targets in Toll-like receptor signaling. PLoS computational biology 2009, 5(2):e1000292-e1000292.
  
• Li S, Min JY, Krug RM, Sen GC: Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. Virology 2006, 349(1):13-21.
  
• Li X, Palese P: Characterization of the polyadenylation signal of influenza virus RNA. Journal of virology 1994, 68(2):1245-1249.
  
• Li Y, Anderson DH, Liu Q, Zhou Y: Mechanism of influenza A virus NS1 protein interaction with the p85beta, but not the p85alpha, subunit of phosphatidylinositol 3-kinase (PI3K) and up-regulation of PI3K activity. J Biol Chem 2008, 283(34):23397-23409.
  
• Lin C, Zimmer SG, Lu Z, Holland RE, Jr., Dong Q, Chambers TM: The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis. Virology 2001, 287(1):202-213.
  
• Lin S, Naim HY, Rodriguez AC, Roth MG: Mutations in the middle of the transmembrane domain reverse the polarity of transport of the influenza virus hemagglutinin in MDCK epithelial cells. The Journal of cell biology 1998, 142(1):51-57.
  
• Liu H, Golebiewski L, Dow EC, Krug RM, Javier RT, Rice AP: The ESEV PDZ-binding motif of the avian influenza A virus NS1 protein protects infected cells from apoptosis by directly targeting Scribble. Journal of virology 2010, 84(21):11164-11174.
  
• Liu Y-Y, Slotine J-J, Barabási A-L: Controllability of complex networks. Nature 2011, 473(7346):167-173.
  
• Lu X, Masic A, Li Y, Shin Y, Liu Q, Zhou Y: The PI3K/Akt pathway inhibits influenza A virus-induced Bax-mediated apoptosis by negatively regulating the JNK pathway via ASK1. J Gen Virol 2010, 91(Pt 6):1439-1449.
  
• Lu Y, Qian XY, Krug RM: The influenza virus NS1 protein: a novel inhibitor of pre-mRNA splicing. Genes Dev 1994, 8(15):1817-1828.
  
• Lu Y, Wambach M, Katze MG, Krug RM: Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor. Virology 1995, 214(1):222-228.
  
• Ludwig S, Ehrhardt C, Neumeier ER, Kracht M, Rapp UR, Pleschka S: Influenza virus-induced AP-1-dependent gene expression requires activation of the JNK signaling pathway. J Biol Chem 2001, 276(24):10990-10998.
  
• Ludwig S, Wolff T, Ehrhardt C, Wurzer WJ, Reinhardt J, Planz O, Pleschka S: MEK inhibition impairs influenza B virus propagation without emergence of resistant variants. FEBS Lett 2004, 561(1-3):37-43.
  
• Ludwig S: Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biological chemistry 2011, 392(10):837-847.
  
• Lund JM, Alexopoulou L, Sato A, Karow M, Adams NC, Gale NW, Iwasaki A, Flavell RA: Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc Natl Acad Sci U S A 2004, 101(15):5598-5603.
  
• Luni C, Shoemaker JE, Sanft KR, Petzold LR, Doyle FJ, 3rd: Confidence from uncertainty--a multi-target drug screening method from robust control theory. BMC systems biology 2010, 4:161.
  
• Luo GX, Luytjes W, Enami M, Palese P: The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. Journal of virology 1991, 65(6):2861-2867.
  
• Mahmoudian S, Auerochs S, Grone M, Marschall M: Influenza A virus proteins PB1 and NS1 are subject to functionally important phosphorylation by protein kinase C. J Gen Virol 2009, 90(Pt 6):1392-1397.
  
• Marjuki H, Gornitzky A, Marathe BM, Ilyushina NA, Aldridge JR, Desai G, Webby RJ, Webster RG: Influenza A virus-induced early activation of ERK and PI3K mediates V-ATPase-dependent intracellular pH change required for fusion. Cell Microbiol 2011, 13(4):587-601.
  
• Marsolais D, Hahm B, Walsh KB, Edelmann KH, McGavern D, Hatta Y, Kawaoka Y, Rosen H, Oldstone MB: A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc Natl Acad Sci U S A 2009, 106(5):1560-1565.
  
• Martin K, Helenius A: Nuclear transport of influenza virus ribonucleoproteins: the viral matrix protein (M1) promotes export and inhibits import. Cell 1991, 67(1):117-130.
  
• Martin K, Helenius A: Transport of incoming influenza virus nucleocapsids into the nucleus. Journal of virology 1991, 65(1):232-244.
  
• Maruoka S, Hashimoto S, Gon Y, Nishitoh H, Takeshita I, Asai Y, Mizumura K, Shimizu K, Ichijo H, Horie T: ASK1 regulates influenza virus infection-induced apoptotic cell death. Biochem Biophys Res Commun 2003, 307(4):870-876.
  
• Matlin KS, Reggio H, Helenius A, Simons K: Infectious entry pathway of influenza virus in a canine kidney cell line. The Journal of cell biology 1981, 91(3 Pt 1):601-613.
  
• Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, Castrucci MR, Donatelli I, Kawaoka Y: Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. Journal of virology 2000, 74(18):8502-8512.
  
• Matrosovich MN, Matrosovich TY, Gray T, Roberts NA, Klenk HD: Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A 2004, 101(13):4620-4624.
  
• Matsuoka Y, Ghosh S, Kikuchi N, Kitano H: Payao: a community platform for SBML pathway model curation. Bioinformatics (Oxford, England) 2010, 26(10):1381-1383.
  
• Matthews L, Gopinath G, Gillespie M, Caudy M, Croft D, de Bono B, Garapati P, Hemish J, Hermjakob H, Jassal B et al: Reactome knowledgebase of human biological pathways and processes. Nucleic acids research 2009, 37(Database issue):D619-D622.
  
• Mayer D, Molawi K, Martinez-Sobrido L, Ghanem A, Thomas S, Baginsky S, Grossmann J, Garcia-Sastre A, Schwemmle M: Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. Journal of proteome research 2007, 6(2):672-682.
  
• Mazur I, Anhlan D, Mitzner D, Wixler L, Schubert U, Ludwig S: The proapoptotic influenza A virus protein PB1-F2 regulates viral polymerase activity by interaction with the PB1 protein. Cell Microbiol 2008, 10(5):1140-1152.
  
• Mazur I, Wurzer WJ, Ehrhardt C, Pleschka S, Puthavathana P, Silberzahn T, Wolff T, Planz O, Ludwig S: Acetylsalicylic acid (ASA) blocks influenza virus propagation via its NF-kappaB-inhibiting activity. Cell Microbiol 2007, 9(7):1683-1694.
  
• McAuley JL, Chipuk JE, Boyd KL, Van De Velde N, Green DR, McCullers JA: PB1-F2 proteins from H5N1 and 20 century pandemic influenza viruses cause immunopathology. PLoS Pathog 2010, 6(7):e1001014.
  
• McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA: Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. Cell Host Microbe 2007, 2(4):240-249.
  
• McCown MF, Pekosz A: The influenza A virus M2 cytoplasmic tail is required for infectious virus production and efficient genome packaging. Journal of virology 2005, 79(6):3595-3605.
  
• Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, Guo N, Muruganujan A, Doremieux O, Campbell MJ et al: The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic acids research 2005, 33(suppl 1):D284-D288.
  
• Mibayashi M, Martinez-Sobrido L, Loo YM, Cardenas WB, Gale M, Jr., Garcia-Sastre A: Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus. Journal of virology 2007, 81(2):514-524.
  
• Min JY, Krug RM: The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway. Proc Natl Acad Sci U S A 2006, 103(18):7100-7105.
  
• Min JY, Li S, Sen GC, Krug RM: A site on the influenza A virus NS1 protein mediates both inhibition of PKR activation and temporal regulation of viral RNA synthesis. Virology 2007, 363(1):236-243.
  
• Mitzner D, Dudek SE, Studtrucker N, Anhlan D, Mazur I, Wissing J, Jansch L, Wixler L, Bruns K, Sharma A et al: Phosphorylation of the influenza A virus protein PB1-F2 by PKC is crucial for apoptosis promoting functions in monocytes. Cell Microbiol 2009, 11(10):1502-1516.
  
• Momose F, Basler CF, O'Neill RE, Iwamatsu A, Palese P, Nagata K: Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. Journal of virology 2001, 75(4):1899-1908.
  
• Momose F, Handa H, Nagata K: Identification of host factors that regulate the influenza virus RNA polymerase activity. Biochimie 1996, 78(11-12):1103-1108.
  
• Momose F, Kikuchi Y, Komase K, Morikawa Y: Visualization of microtubule-mediated transport of influenza viral progeny ribonucleoprotein. Microbes and infection / Institut Pasteur 2007, 9(12-13):1422-1433.
  
• Momose F, Sekimoto T, Ohkura T, Jo S, Kawaguchi A, Nagata K, Morikawa Y: Apical transport of influenza A virus ribonucleoprotein requires Rab11-positive recycling endosome. PLoS One 2011, 6(6):e21123.
  
• Mori I, Goshima F, Koshizuka T, Koide N, Sugiyama T, Yoshida T, Yokochi T, Nishiyama Y, Kimura Y: Differential activation of the c-Jun N-terminal kinase/stress-activated protein kinase and p38 mitogen-activated protein kinase signal transduction pathways in the mouse brain upon infection with neurovirulent influenza A virus. J Gen Virol 2003, 84(Pt 9):2401-2408.
  
• Mukaigawa J, Nayak DP: Two signals mediate nuclear localization of influenza virus (A/WSN/33) polymerase basic protein 2. Journal of virology 1991, 65(1):245-253.
  
• Nagata K, Kawaguchi A, Naito T: Host factors for replication and transcription of the influenza virus genome. Rev Med Virol 2008, 18(4):247-260.
  
• Narayanan A, Bailey C, Kashanchi F, Kehn-Hall K: Developments in antivirals against influenza, smallpox and hemorrhagic fever viruses. Expert opinion on investigational drugs 2011, 20(2):239-254.
  
• Nath ST, Nayak DP: Function of two discrete regions is required for nuclear localization of polymerase basic protein 1 of A/WSN/33 influenza virus (H1 N1). Molecular and cellular biology 1990, 10(8):4139-4145.
  
• Nayak DP, Hui EK, Barman S: Assembly and budding of influenza virus. Virus Res 2004, 106(2):147-165.
  
• Neumann G, Brownlee GG, Fodor E, Kawaoka Y: Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol 2004, 283:121-143.
  
• Neumann G, Castrucci MR, Kawaoka Y: Nuclear import and export of influenza virus nucleoprotein. Journal of virology 1997, 71(12):9690-9700.
  
• Neumann G, Hughes MT, Kawaoka Y: Influenza A virus NS2 protein mediates vRNP nuclear export through NES-independent interaction with hCRM1. EMBO J 2000, 19(24):6751-6758.
  
• Nguyen HT, Fry AM, Gubareva LV: Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods. Antiviral therapy 2012, 17(1 Pt B):159-173.
  
• Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL, Wong MP, Chui WH, Poon LL, Tsao SW et al: Tropism of avian influenza A (H5N1) in the upper and lower respiratory tract. Nat Med 2007, 13(2):147-149.
  
• Nicholls JM, Chan RW, Russell RJ, Air GM, Peiris JS: Evolving complexities of influenza virus and its receptors. Trends in microbiology 2008, 16(4):149-157.
  
• Nieto A, de la Luna S, Bárcena J, Portela A, Ortín J: Complex structure of the nuclear translocation signal of influenza virus polymerase PA subunit. J Gen Virol 1994, 75 ( Pt 1):29-36.
  
• Noah DL, Twu KY, Krug RM: Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS. Virology 2003, 307(2):386-395.
  
• Nunes-Correia I, Eulalio A, Nir S, Pedroso de Lima MC: Caveolae as an additional route for influenza virus endocytosis in MDCK cells. Cellular & molecular biology letters 2004, 9(1):47-60.
  
• Obenauer JC, Denson J, Mehta PK, Su X, Mukatira S, Finkelstein DB, Xu X, Wang J, Ma J, Fan Y et al: Large-scale sequence analysis of avian influenza isolates. Science 2006, 311(5767):1576-1580.
  
• Oda K, Kitano H: A comprehensive map of the toll-like receptor signaling network. Molecular systems biology 2006, 2:2006.0015-2006.0015.
  
• Oda K, Matsuoka Y, Funahashi A, Kitano H: A comprehensive pathway map of epidermal growth factor receptor signaling. Molecular systems biology 2005, 1:2005.0010-2005.0010.
  
• Olschlager V, Pleschka S, Fischer T, Rziha HJ, Wurzer W, Stitz L, Rapp UR, Ludwig S, Planz O: Lung-specific expression of active Raf kinase results in increased mortality of influenza A virus-infected mice. Oncogene 2004, 23(39):6639-6646.
  
• O'Neill RE, Jaskunas R, Blobel G, Palese P, Moroianu J: Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem 1995, 270(39):22701-22704.
  
• O'Neill RE, Palese P: NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology 1995, 206(1):116-125.
  
• O'Neill RE, Talon J, Palese P: The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J 1998, 17(1):288-296.
  
• Opitz B, Rejaibi A, Dauber B, Eckhard J, Vinzing M, Schmeck B, Hippenstiel S, Suttorp N, Wolff T: IFNbeta induction by influenza A virus is mediated by RIG-I which is regulated by the viral NS1 protein. Cell Microbiol 2007, 9(4):930-938.
  
• Pal S, Rosas JM, Rosas-Acosta G: Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs. Journal of virological methods 2010, 163(2):498-504.
  
• Pal S, Santos A, Rosas JM, Ortiz-Guzman J, Rosas-Acosta G: Influenza A virus interacts extensively with the cellular SUMOylation system during infection. Virus Res 2011, 158(1-2):12-27.
  
• Palmer R: Drugs: Lines of defence. Nature 2011, 480(7376):S9-10.
  
• Park YW, Katze MG: Translational control by influenza virus. Identification of cis-acting sequences and trans-acting factors which may regulate selective viral mRNA translation. J Biol Chem 1995, 270(47):28433-28439.
  
• Paterson D, Fodor E: Emerging roles for the influenza A virus nuclear export protein (NEP). PLoS Pathog 2012, 8(12):e1003019.
  
• Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reis e Sousa C: RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314(5801):997-1001.
  
• Pillai SP, Lee CW: Species and age related differences in the type and distribution of influenza virus receptors in different tissues of chickens, ducks and turkeys. Virol J 2010, 7:5.
  
• Pirhonen J, Sareneva T, Kurimoto M, Julkunen I, Matikainen S: Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway. J Immunol 1999, 162(12):7322-7329.
  
• Pleschka S, Wolff T, Ehrhardt C, Hobom G, Planz O, Rapp UR, Ludwig S: Influenza virus propagation is impaired by inhibition of the Raf/MEK/ERK signalling cascade. Nat Cell Biol 2001, 3(3):301-305.
  
• Poon LL, Pritlove DC, Fodor E, Brownlee GG: Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. Journal of virology 1999, 73(4):3473-3476.
  
• Privalsky ML, Penhoet EE: The structure and synthesis of influenza virus phosphoproteins. J Biol Chem 1981, 256(11):5368-5376.
  
• Qian XY, Alonso-Caplen F, Krug RM: Two functional domains of the influenza virus NS1 protein are required for regulation of nuclear export of mRNA. Journal of virology 1994, 68(4):2433-2441.
  
• Qiu Y, Krug RM: The influenza virus NS1 protein is a poly(A)-binding protein that inhibits nuclear export of mRNAs containing poly(A). Journal of virology 1994, 68(4):2425-2432.
  
• Qiu Y, Nemeroff M, Krug RM: The influenza virus NS1 protein binds to a specific region in human U6 snRNA and inhibits U6-U2 and U6-U4 snRNA interactions during splicing. Rna 1995, 1(3):304-316.
  
• Reinhardt J, Wolff T: The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet Microbiol 2000, 74(1-2):87-100.
  
• Resa-Infante P, Jorba N, Zamarreno N, Fernandez Y, Juarez S, Ortin J: The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication. PLoS One 2008, 3(12):e3904.
  
• Riner A, Chan-Tack KM, Murray JS: Original research: Intravenous ribavirin--review of the FDA's Emergency Investigational New Drug Database (1997-2008) and literature review. Postgraduate medicine 2009, 121(3):139-146.
  
• Robertson JS, Schubert M, Lazzarini RA: Polyadenylation sites for influenza virus mRNA. Journal of virology 1981, 38(1):157-163.
  
• Rogers GN, Paulson JC: Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 1983, 127(2):361-373.
  
• Rogers GN, Pritchett TJ, Lane JL, Paulson JC: Differential sensitivity of human, avian, and equine influenza A viruses to a glycoprotein inhibitor of infection: selection of receptor specific variants. Virology 1983, 131(2):394-408.
  
• Rossman JS, Jing X, Leser GP, Lamb RA: Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 2010, 142(6):902-913.
  
• Rossman JS, Leser GP, Lamb RA: Filamentous Influenza Virus Enters Cells via Macropinocytosis. Journal of virology 2012, 86(20):10950-10960.
  
• Ruigrok RW, Barge A, Durrer P, Brunner J, Ma K, Whittaker GR: Membrane interaction of influenza virus M1 protein. Virology 2000, 267(2):289-298.
  
• Saito T, Kawano K: Loss of glycosylation at Asn144 alters the substrate preference of the N8 influenza A virus neuraminidase. The Journal of veterinary medical science / the Japanese Society of Veterinary Science 1997, 59(10):923-926.
  
• Satterly N, Tsai PL, van Deursen J, Nussenzveig DR, Wang Y, Faria PA, Levay A, Levy DE, Fontoura BM: Influenza virus targets the mRNA export machinery and the nuclear pore complex. Proc Natl Acad Sci U S A 2007, 104(6):1853-1858.
  
• Scheiffele P, Roth MG, Simons K: Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J 1997, 16(18):5501-5508.
  
• Schneider J, Wolff T: Nuclear functions of the influenza A and B viruses NS1 proteins: do they play a role in viral mRNA export? Vaccine 2009, 27(45):6312-6316.
  
• Schroeder C, Heider H, Moncke-Buchner E, Lin TI: The influenza virus ion channel and maturation cofactor M2 is a cholesterol-binding protein. European biophysics journal : EBJ 2005, 34(1):52-66.
  
• Service RF: Researchers seek new weapon against the flu. Science 1997, 275(5301):756-757.
  
• Shapira SD, Gat-Viks I, Shum BO, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE et al: A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 2009, 139(7):1255-1267.
  
• Shaw ML, Stone KL, Colangelo CM, Gulcicek EE, Palese P: Cellular proteins in influenza virus particles. PLoS Pathog 2008, 4(6):e1000085.
  
• Shin YK, Li Y, Liu Q, Anderson DH, Babiuk LA, Zhou Y: SH3 binding motif 1 in influenza A virus NS1 protein is essential for PI3K/Akt signaling pathway activation. Journal of virology 2007, 81(23):12730-12739.
  
• Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y: Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation. J Gen Virol 2007, 88(Pt 3):942-950.
  
• Shin YK, Liu Q, Tikoo SK, Babiuk LA, Zhou Y: Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J Gen Virol 2007, 88(Pt 1):13-18.
  
• Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y: Avian flu: influenza virus receptors in the human airway. Nature 2006, 440(7083):435-436.
  
• Sieczkarski SB, Whittaker GR: Differential requirements of Rab5 and Rab7 for endocytosis of influenza and other enveloped viruses. Traffic 2003, 4(5):333-343.
  
• Sieczkarski SB, Whittaker GR: Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. Journal of virology 2002, 76(20):10455-10464.
  
• Sielaff F, Bottcher-Friebertshauser E, Meyer D, Saupe SM, Volk IM, Garten W, Steinmetzer T: Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT. Bioorganic & medicinal chemistry letters 2011, 21(16):4860-4864.
  
• Skehel JJ, Wiley DC: Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000, 69:531-569.
  
• Sleeman K, Mishin VP, Deyde VM, Furuta Y, Klimov AI, Gubareva LV: In vitro antiviral activity of favipiravir (T-705) against drug-resistant influenza and 2009 A(H1N1) viruses. Antimicrob Agents Chemother 2010, 54(6):2517-2524.
  
• Smith AM, Adler FR, McAuley JL, Gutenkunst RN, Ribeiro RM, McCullers JA, Perelson AS: Effect of 1918 PB1-F2 expression on influenza A virus infection kinetics. PLoS Comput Biol 2011, 7(2):e1001081.
  
• Smith GL, Levin JZ, Palese P, Moss B: Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology 1987, 160(2):336-345.
  
• Soubies SM, Volmer C, Croville G, Loupias J, Peralta B, Costes P, Lacroux C, Guerin JL, Volmer R: Species-specific contribution of the four C-terminal amino acids of influenza A virus NS1 protein to virulence. Journal of virology 2010, 84(13):6733-6747.
  
• Squires RB, Noronha J, Hunt V, Garcia-Sastre A, Macken C, Baumgarth N, Suarez D, Pickett BE, Zhang Y, Larsen CN et al: Influenza research database: an integrated bioinformatics resource for influenza research and surveillance. Influenza and other respiratory viruses 2012, 6(6):404-416.
  
• Staeheli P, Haller O, Boll W, Lindenmann J, Weissmann C: Mx protein: constitutive expression in 3T3 cells transformed with cloned Mx cDNA confers selective resistance to influenza virus. Cell 1986, 44(1):147-158.
  
• Starko KM: Salicylates and pandemic influenza mortality, 1918-1919 pharmacology, pathology, and historic evidence. Clin Infect Dis 2009, 49(9):1405-1410.
  
• Stasakova J, Ferko B, Kittel C, Sereinig S, Romanova J, Katinger H, Egorov A: Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18. J Gen Virol 2005, 86(Pt 1):185-195.
  
• Stertz S, Shaw ML: Uncovering the global host cell requirements for influenza virus replication via RNAi screening. Microbes and infection / Institut Pasteur 2011, 13(5):516-525.
• Stieneke-Grober A, Vey M, Angliker H, Shaw E, Thomas G, Roberts C, Klenk HD, Garten W: Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J 1992, 11(7):2407-2414.
  
• Su CY, Cheng TJ, Lin MI, Wang SY, Huang WI, Lin-Chu SY, Chen YH, Wu CY, Lai MM, Cheng WC et al: High-throughput identification of compounds targeting influenza RNA-dependent RNA polymerase activity. Proc Natl Acad Sci U S A 2010, 107(45):19151-19156.
  
• Sugiyama K, Kamada T, Shimizu K, Watanabe Y: Preferential phosphorylation of NP-protein of influenza A2 virus by virion-associated protein kinase. Japanese journal of microbiology 1976, 20(3):227-232.
  
• Sui B, Bamba D, Weng K, Ung H, Chang S, Van Dyke J, Goldblatt M, Duan R, Kinch MS, Li WB: The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza. Virology 2009, 387(2):473-481.
  
• Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, Santelli E, Stec B, Cadwell G, Ali M et al: Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat Struct Mol Biol 2009, 16(3):265-273.
  
• Sun E, He J, Zhuang X: Dissecting the role of COPI complexes in influenza virus infection. Journal of virology 2013, 87(5):2673-2685.
  
• Takeda M, Leser GP, Russell CJ, Lamb RA: Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion. Proc Natl Acad Sci U S A 2003, 100(25):14610-14617.
  
• Tamura M, Webster RG, Ennis FA: Neutralization and infection-enhancement epitopes of influenza A virus hemagglutinin. J Immunol 1993, 151(3):1731-1738.
  
• Tan SL, Katze MG: Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase. J Interferon Cytokine Res 1998, 18(9):757-766.
  
• Tang Y, Zhong G, Zhu L, Liu X, Shan Y, Feng H, Bu Z, Chen H, Wang C: Herc5 attenuates influenza A virus by catalyzing ISGylation of viral NS1 protein. J Immunol 2010, 184(10):5777-5790.
  
• Taylor HP, Armstrong SJ, Dimmock NJ: Quantitative relationships between an influenza virus and neutralizing antibody. Virology 1987, 159(2):288-298.
  
• Taylor HP, Dimmock NJ: Competitive binding of neutralizing monoclonal and polyclonal IgG to the HA of influenza A virions in solution: only one IgG molecule is bound per HA trimer regardless of the specificity of the competitor. Virology 1994, 205(1):360-363.
  
• Thomas M, Kranjec C, Nagasaka K, Matlashewski G, Banks L: Analysis of the PDZ binding specificities of Influenza A virus NS1 proteins. Virol J 2011, 8:25.
  
• Thomas PG, Dash P, Aldridge JR, Jr., Ellebedy AH, Reynolds C, Funk AJ, Martin WJ, Lamkanfi M, Webby RJ, Boyd KL et al: The intracellular sensor NLRP3 mediates key innate and healing responses to influenza A virus via the regulation of caspase-1. Immunity 2009, 30(4):566-575.
  
• Triana-Baltzer GB, Gubareva LV, Klimov AI, Wurtman DF, Moss RB, Hedlund M, Larson JL, Belshe RB, Fang F: Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein. PLoS One 2009, 4(11):e7838.
  
• Triana-Baltzer GB, Gubareva LV, Nicholls JM, Pearce MB, Mishin VP, Belser JA, Chen LM, Chan RW, Chan MC, Hedlund M et al: Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein. PLoS One 2009, 4(11):e7788.
  
• Turan K, Mibayashi M, Sugiyama K, Saito S, Numajiri A, Nagata K: Nuclear MxA proteins form a complex with influenza virus NP and inhibit the transcription of the engineered influenza virus genome. Nucleic Acids Res 2004, 32(2):643-652.
  
• Ulmanen I, Broni BA, Krug RM: Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription. Proceedings of the National Academy of Sciences of the United States of America 1981, 78(12):7355-7359.
  
• van Riel D, Munster VJ, de Wit E, Rimmelzwaan GF, Fouchier RA, Osterhaus AD, Kuiken T: H5N1 Virus Attachment to Lower Respiratory Tract. Science 2006, 312(5772):399.
  
• van Zeijl MJ, Matlin KS: Microtubule perturbation inhibits intracellular transport of an apical membrane glycoprotein in a substrate-dependent manner in polarized Madin-Darby canine kidney epithelial cells. Cell regulation 1990, 1(12):921-936.
  
• Varga ZT, Ramos I, Hai R, Schmolke M, Garcia-Sastre A, Fernandez-Sesma A, Palese P: The influenza virus protein PB1-F2 inhibits the induction of type I interferon at the level of the MAVS adaptor protein. PLoS Pathog 2011, 7(6):e1002067.
  
• Veit M: Palmitoylation of virus proteins. Biology of the cell / under the auspices of the European Cell Biology Organization 2012, 104(9):493-515.
  
• Virelizier JL: Host defenses against influenza virus: the role of anti-hemagglutinin antibody. J Immunol 1975, 115(2):434-439.
  
• Viswanathan K, Chandrasekaran A, Srinivasan A, Raman R, Sasisekharan V, Sasisekharan R: Glycans as receptors for influenza pathogenesis. Glycoconjugate journal 2010, 27(6):561-570.
  
• von Itzstein M, Wu WY, Kok GB, Pegg MS, Dyason JC, Jin B, Van Phan T, Smythe ML, White HF, Oliver SW et al: Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 1993, 363(6428):418-423.
  
• Wagner R, Matrosovich M, Klenk HD: Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol 2002, 12(3):159-166.
  
• Walkiewicz MP, Basu D, Jablonski JJ, Geysen HM, Engel DA: Novel inhibitor of influenza non-structural protein 1 blocks multi-cycle replication in an RNase L-dependent manner. J Gen Virol 2011, 92(Pt 1):60-70.
  
• Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, Watanabe T, Hatta M, Shinya K, Suresh M et al: Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A 2011, 108(29):12018-12023.
  
• Wang P, Palese P, O'Neill RE: The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. Journal of virology 1997, 71(3):1850-1856.
  
• Wang W, Krug RM: U6atac snRNA, the highly divergent counterpart of U6 snRNA, is the specific target that mediates inhibition of AT-AC splicing by the influenza virus NS1 protein. Rna 1998, 4(1):55-64.
  
• Wang X, Hinson ER, Cresswell P: The interferon-inducible protein viperin inhibits influenza virus release by perturbing lipid rafts. Cell Host Microbe 2007, 2(2):96-105.
  
• Watanabe T, Watanabe S, Kawaoka Y: Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 2010, 7(6):427-439.
  
• Weber F, Kochs G, Gruber S, Haller O: A classical bipartite nuclear localization signal on Thogoto and influenza A virus nucleoproteins. Virology 1998, 250(1):9-18.
  
• Webster RG, Rott R: Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell 1987, 50(5):665-666.
  
• Whittaker G, Bui M, Helenius A: Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons. Journal of virology 1996, 70(5):2743-2756.
  
• Whittaker G, Kemler I, Helenius A: Hyperphosphorylation of mutant influenza virus matrix protein, M1, causes its retention in the nucleus. Journal of virology 1995, 69(1):439-445.
  
• Wilks S, de Graaf M, Smith DJ, Burke DF: A review of influenza haemagglutinin receptor binding as it relates to pandemic properties. Vaccine 2012, 30(29):4369-4376.
  
• Woods JM, Bethell RC, Coates JA, Healy N, Hiscox SA, Pearson BA, Ryan DM, Ticehurst J, Tilling J, Walcott SM et al: 4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid is a highly effective inhibitor both of the sialidase (neuraminidase) and of growth of a wide range of influenza A and B viruses in vitro. Antimicrob Agents Chemother 1993, 37(7):1473-1479.
  
• Wu CY, Jeng KS, Lai MM: The SUMOylation of matrix protein M1 modulates the assembly and morphogenesis of influenza A virus. Journal of virology 2011, 85(13):6618-6628.
  
• Wu WW, Sun YH, Pante N: Nuclear import of influenza A viral ribonucleoprotein complexes is mediated by two nuclear localization sequences on viral nucleoprotein. Virol J 2007, 4:49.
  
• Xing Z, Cardona CJ, Anunciacion J, Adams S, Dao N: Roles of the ERK MAPK in the regulation of proinflammatory and apoptotic responses in chicken macrophages infected with H9N2 avian influenza virus. J Gen Virol 2010, 91(Pt 2):343-351.
  
• Xu K, Klenk C, Liu B, Keiner B, Cheng J, Zheng BJ, Li L, Han Q, Wang C, Li T et al: Modification of nonstructural protein 1 of influenza A virus by SUMO1. Journal of virology 2011, 85(2):1086-1098.
  
• Yamada H, Chounan R, Higashi Y, Kurihara N, Kido H: Mitochondrial targeting sequence of the influenza A virus PB1-F2 protein and its function in mitochondria. FEBS Lett 2004, 578(3):331-336.
  
• Yan N, Chen ZJ: Intrinsic antiviral immunity. Nature immunology 2012, 13(3):214-222.
  
• Yanguez E, Castello A, Welnowska E, Carrasco L, Goodfellow I, Nieto A: Functional impairment of eIF4A and eIF4G factors correlates with inhibition of influenza virus mRNA translation. Virology 2011, 413(1):93-102.
  
• Yanguez E, Rodriguez P, Goodfellow I, Nieto A: Influenza virus polymerase confers independence of the cellular cap-binding factor eIF4E for viral mRNA translation. Virology 2011.
  
• Yao L, Korteweg C, Hsueh W, Gu J: Avian influenza receptor expression in H5N1-infected and noninfected human tissues. FASEB J 2008, 22(3):733-740.
  
• Yasuda J, Nakada S, Kato A, Toyoda T, Ishihama A: Molecular assembly of influenza virus: association of the NS2 protein with virion matrix. Virology 1993, 196(1):249-255.
  
• Ye Z, Liu T, Offringa DP, McInnis J, Levandowski RA: Association of influenza virus matrix protein with ribonucleoproteins. Journal of virology 1999, 73(9):7467-7473.
  
• Ye Z, Robinson D, Wagner RR: Nucleus-targeting domain of the matrix protein (M1) of influenza virus. Journal of virology 1995, 69(3):1964-1970.
  
• Yewdell JW, Taylor A, Yellen A, Caton A, Gerhard W, Bachi T: Mutations in or near the fusion peptide of the influenza virus hemagglutinin affect an antigenic site in the globular region. Journal of virology 1993, 67(2):933-942.
  
• York A, Fodor E: Biogenesis, assembly and export of viral messenger ribonucleoproteins in the influenza A virus infected cell. RNA biology 2013, 10(8).
  
• Yount JS, Moltedo B, Yang YY, Charron G, Moran TM, Lopez CB, Hang HC: Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat Chem Biol 2010, 6(8):610-614.
  
• Zamarin D, Garcia-Sastre A, Xiao X, Wang R, Palese P: Influenza virus PB1-F2 protein induces cell death through mitochondrial ANT3 and VDAC1. PLoS Pathog 2005, 1(1):e4.
  
• Zamarin D, Ortigoza MB, Palese P: Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice. Journal of virology 2006, 80(16):7976-7983.
  
• Zhang J, Lamb RA: Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology 1996, 225(2):255-266.
  
• Zhang J, Pekosz A, Lamb RA: Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins. Journal of virology 2000, 74(10):4634-4644.
  
• Zhao C, Hsiang TY, Kuo RL, Krug RM: ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proc Natl Acad Sci U S A 2010, 107(5):2253-2258.
  
• Zhirnov OP, Klenk HD: Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis 2007, 12(8):1419-1432.
  
• Zhirnov OP, Konakova TE, Wolff T, Klenk HD: NS1 protein of influenza A virus down-regulates apoptosis. Journal of virology 2002, 76(4):1617-1625.
  
• Zhirnov OP, Ovcharenko AV, Bukrinskaya AG: Suppression of influenza virus replication in infected mice by protease inhibitors. J Gen Virol 1984, 65 ( Pt 1):191-196.
  
• Zielecki F, Semmler I, Kalthoff D, Voss D, Mauel S, Gruber AD, Beer M, Wolff T: Virulence determinants of avian H5N1 influenza A virus in mammalian and avian hosts: role of the C-terminal ESEV motif in the viral NS1 protein. Journal of virology 2010, 84(20):10708-10718.

 

Book sections

• Palese P, Shaw ML (2007) Orthomyxoviridae: The Viruses and Their Replication. In Fields Virology, Fifth Edition, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds), Vol. 2, 47, pp 1647-1689. Philadelphia: Wolters Kluwer; Lippincott Williams & Wilkins
• Wright PF, Neumann G, Kawaoka Y (2007) Orthomyxoviruses. In Fields Virology, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (eds), Vol. 2, Fifth Edition edn, 48, pp 1691-1740. Philadelphia, Baltimore, New York, London, Buenos Aires, Hong Kong, Sydney, Tokyo: Wolters Kluwer; Lippincott Williams & Wilkins

 

Applications

• CellDesigner
• iPathways+

 

2013 ERATO KAWAOKA Infection-induced Host Responses project